The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

International Journal of Obesity

Volumn 23, Issue 10, 1999, Pages 1009-1015

  Walsh, K M ^b   Leen, E ^b   Lean, M E J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

Cardiac output; Energy expenditure; Obesity; Sibutramine; Thermogenesis; Weight loss

Indexed keywords

ADRENALIN; PLACEBO; SIBUTRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; DIET THERAPY; DOPPLER ECHOGRAPHY; ENERGY EXPENDITURE; FEMALE; HEART OUTPUT; HEART RATE; HUMAN; HYPOTHESIS; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; THERMOGENESIS;

EID: 0007379609     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801045     Document Type: Article

References (28)

1. 1 Lean MEJ. Sibutramine - a review of clinical efficacy. Int J Obes 1997; 21: S30-S36.
2. 2 Boots Pharmaceutical Research Report. Effect of sibutramine on oxygen consumption and body temperature in rats. 1994. Report No. BL 94054.
3. 3 Lean MEJ, Han TS, Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr 1996; 63: 4-14.
4. 4 Macdonald I, Lake D. An improved technique for extracting catecholamines from body fluids. J Neurosci Meth 1985; 13: 239-248.
5. 5 Goldberg BB. Suprasternal ultrasonography. JAMA 1971; 215: 245-250.
6. 2- rebreathing and the direct Fick method. Acta Anaesthesiol Scand 1995; 39: 245-251.
7. 7 Hadjis T, Jobin J, Bourbeau J, Desagagnes P, Juneau L, Sampalis J. Aortic flow velocity indices during upright exercise: reliability and relationship to cardiac output. Can J Cardiol 1995; 11: 100-104.
8. 8 Ferranini E. The theoretical basis of indirect calorimetry: a review. Metabolism 1988; 37: 287-301.
9. 9 McGuire E, Helderman J, Tobin J, Andres R, Berman M. Effects of arterial venous versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976; 41: 565-573.
10. 10 Clutter W, Bier D, Shah S, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980; 66: 94-101.
11. 11 Sjostrom L, Schutz Y, Gudinchet F, Hegnell L, Pittet PG, Jequier E. Epinephrine sensitivity with respect to metabolic rate and other variables in women. Am J Physiol 1983; 245: E431-E442.
12. 12 Armitage P, Berry G. Statistical Methods in Medical Research. 2nd edition: Blackwell Scientific: Oxford, 1994.
13. 13 Webber J, Taylor J, Greathead H, Dawson J, Buttery P, Macdonald I. A comparison of the thermogenic, metabolic and haemodynamic responses to infused adrenaline in lean and obese subjects. Int J Obes 1994; 18: 717-724.
14. 14 Durnin JVGA, Womersley J. The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine. Br J Pharmacol 1973; 49: 115-120.
15. 15 Garrow JS, Belton EA, Daniels A. A controlled investigation of the 'glycolyptic' action of fenfluramine. Lancet 1972; 2: 559-561.
16. 16 Petric JC, Mowat JA, Bewsher PD, Stowers JM. Metabolic effects of fenfluramine: a double blind study. Postgrad Med J 1975; 51 (suppl 1): S139-S144.
17. 17 Lafreniere F, Lambert J, Rasio E, Serri O. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study. Int J Obes 1993; 17: 25-30.
18. 18 Recasens MA, Barenys M, Sola R, Blanch S, Masana L, Salas-Salvado J. Effect of dexfenfluramine on energy expenditure in obese patients on a very low calorie diet. Int J Obes 1995; 19: 162-168.
19. 19 Van Gaal LF, Vansant GA, Steijart MC, De Leeuw IH. Effects of dexfenfluramine on resting metabolic rate and thermogenesis in premenopausal obese women during therapeutic weight reduction. Metabolism 1995; 44 (Suppl 2): S42-S45.
20. 20 Scalfi L, D'Arrigo E, Carandente V, Coltorti A, Contaldo F. The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects; a double-blind placebo-controlled study. Int J Obes 1993; 17: 91-96.
21. 21 Bross R, Hoffer LJ. Fluoxeline increases resting energy expenditure and basal body temperature in humans. Am J Clin Nutr 1995; 61: 1020-1025.
22. 22 Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol 1978; 234: E252-E256.
23. 23 Galbo H, Holst J, Christensen N. Glucagon and plasma catecholamine response to graded and prolonged exercise in man. J Apply Physiol 1975; 38: 70-76.
24. 24 Cryer PE, Santiago J, Shah S. Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab 1974; 39: 1025-1029.
25. 25 Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998; 68: 1180-1186.
26. 26 Connolly IP, Frost I, Heal DJ, Stock MJ. Role of beta-adrenoceptors in mediating the thermogenic effects of sibutramine. (Abstract) . Br J Pharmacol 1995; 170P.
27. 27 Schofield WN. Predicting basal metabolic rate, new standards, and review of previous work. Hum Nutr Clin Nutr 1985; 39 (Suppl 1): S5-S41.
28. 28 Nair KS, Halliday D, Garrow JS. Thermic response to iso-energetic protein, carbohydrate or fat meals in lean and obese subjects. Clin Sci 1983; 65: 307-312.